<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Disease Management on Critical Social Epidemiology Research Collaborative</title>
    <link>https://criticalsocialepi.org/tags/disease-management/</link>
    <description>Recent content in Disease Management on Critical Social Epidemiology Research Collaborative</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <lastBuildDate>Fri, 01 Jan 2016 00:00:00 +0000</lastBuildDate><atom:link href="https://criticalsocialepi.org/tags/disease-management/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Weighing the Evidence for Harm from Long-Term Treatment with Antipsychotic Medications: A Systematic Review</title>
      <link>https://criticalsocialepi.org/research/sohler-weighing-2016/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      
      <guid>https://criticalsocialepi.org/research/sohler-weighing-2016/</guid>
      <description>Abstract     Research findings supporting the use of antipsychotic medication for acute treatment of schizophrenia are relatively consistent and undisputed. However, the rationale for recommending long-term antipsychotic medication treatment-the current standard of care treatment strategy-is unclear. A controversial hypothesis proposed recently suggests people with schizophrenia who are exposed to long-term treatment with antipsychotic medications have worse outcomes than people with schizophrenia who are not exposed to these medications.</description>
    </item>
    
  </channel>
</rss>
